Chimerix to Present at the Morgan Stanley Global Healthcare Conference
Sep 06, 2016 12:00 pm UTC| Business
DURHAM, N.C., Sept. 06, 2016 -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company developing novel antivirals to address unmet medical needs, today announced that M. Michelle Berrey, M.D., M.P.H, Chief Executive...
Sep 06, 2016 12:00 pm UTC| Business
SALT LAKE CITY, Sept. 06, 2016 -- Park City Group, Inc. (NASDAQ:PCYG), a cloud-based software company that uses big data management to help retailers and their suppliers ‘Sell more, Stock less and See everything’, today...
Sep 06, 2016 12:00 pm UTC| Business
LOS ANGELES, Sept. 06, 2016 -- WGE Holdings Corp., (OTC:WGEE), to be renamed Consolidated Gold Holdings, today announced it has entered into a preliminary agreement with a major Asian industrial and mining group to...
Cascadian Therapeutics to Present at the Rodman & Renshaw 18th Annual Global Investment Conference
Sep 06, 2016 12:00 pm UTC| Business
SEATTLE, Sept. 06, 2016 -- Cascadian Therapeutics (NASDAQ:CASC), a clinical-stage biopharmaceutical company, today announced that Scott Myers, President and CEO, and Luke Walker, M.D., Vice President of Clinical...
Depomed Announces Presentations at PAINWeek 2016
Sep 06, 2016 12:00 pm UTC| Business
NEWARK, Calif., Sept. 06, 2016 -- Depomed, Inc. (NASDAQ:DEPO) announced today the presentation of ten abstracts at PAINWeek® 2016, the nation's largest annual meeting for frontline clinicians in the area of pain...
MarketAxess Announces Monthly Volume Statistics for August 2016
Sep 06, 2016 12:00 pm UTC| Business
NEW YORK, Sept. 06, 2016 -- MarketAxess Holdings Inc. (Nasdaq:MKTX), the operator of a leading electronic trading platform for fixed-income securities, and the provider of market data and post-trade services for the...
Alder BioPharmaceuticals Appoints Elisabeth A. Sandoval as Chief Commercial Officer
Sep 06, 2016 12:00 pm UTC| Business
BOTHELL, Wash., Sept. 06, 2016 -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics, today announced the appointment of Elisabeth A....